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Abstract
Background: Knowledge of the etiology of pyogenic liver and pancreatic abscesses is an important factor in
determining the success of combined surgical and antibiotic treatment. Literature shows geographical variations in
the prevalence and distribution of causative organisms, and the spread of Klebsiella pneumoniae carbapenemase-
producing bacteria is an emerging cause of abdominal infections.
Case presentation: We herein describe two cases of intra-abdominal abscesses due to monomicrobial infection by
Klebsiella pneumoniae Sequence Type 258 producing K. pneumoniae carbapenemase 3 (KPC-Kp). In case 1, a 50-
year-old HIV-negative Italian woman with chronic pancreatitis showed infection of a pancreatic pseudocystic lesion
caused by KPC-Kp. In case 2, a 64-year-old HIV- negative Italian woman with pancreatic neoplasm and liver
metastases developed a liver abscess due to KPC after surgery. Both women were admitted to our hospital but to
different surgical units. The clonal relationship between the two isolates was investigated by pulsed-field gel
electrophoresis (PFGE). In case 2, the patient was already colonized at admission and inter-hospital transmission of
the pathogen was presumed. A long-term combination regimen of colistin with tigecycline and percutaneous
drainage resulted in full recovery and clearance of the multidrug-resistant (MDR) pathogen.
Conclusions: Timely microbiological diagnosis, the combined use of new and old antibiotics and radiological
intervention appeared to be valuable in managing these serious conditions. The emergence and dissemination of
MDR organisms is posing an increasing challenge for physicians to develop new therapeutic strategies and control
and prevention frameworks.
Keywords: monomicrobial abscess, Klebsiellae pneumoniae, carbapenemases
Background
Pyogenic abdominal abscess caused by carbapenemase-
producing Gram-negative pathogens is an emerging
infection in surgical and intensive care settings. Failure
to timely diagnose these infections and treat them
appropriately has been associated with increased rates of
therapeutic failure and mortality [1-3].
Multidrug resistant (MDR) pathogens in liver or pan-
creatic abscesses have been reported since 1986, but
more recently MDR Klebsiella pneumoniae has been
described as an emerging causative agent [4,5]. More-
over, a high incidence of septic metastatic lesions in
patients with Klebsiella pneumoniae liver abscess has
also been reported [6,7]. Consequently, early detection
with the increasingly significant diagnostic contribution
of computed tomography (CT), as well as a more accu-
rate knowledge of the most likely causative pathogens
and their antibacterial drug resistance patterns, are
critical.
Post-operative abscesses may occur after traditional or
laparoscopic surgery and other micro-invasive techni-
ques [8-11]. Hypermucoviscosity, virulence genes such
as rmpA (regulator of mucoid phenotype) and aerobac-
tin (an iron siderophore) and capsular serotypes K1 and
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determinants in Klebsiella pneumoniae for liver
abscesses [12]. There are predisposing factors that
increase the risk of developing an abscess, most com-
monly linked to bile duct obstruction, metabolic causes
like diabetes ketoacidosis, and nosocomial acquisition
[13]. Enteric organisms are more often able to pass
through the portal venous system or its branches [14].
Thus, intestinal colonization with MDR organisms, such
as carbapenem resistant K. pneumoniae,m a yb ear i s k
factor in critically ill surgical patients. Post-surgical
wound infections involving these organisms have also
been described [15].
However, in some cases the source of infection may
remain undetected and primary abscesses due to viru-
lent clones of K. pneumoniae have been recently
described in otherwise healthy carriers [13,16].
Carbapenem resistance in K. pneumoniae can be
mediated by the production of carbapenemases belonging
to Ambler class A, B or D. The most common carbape-
nemase worldwide is K. pneumoniae carbapenemase
(KPC), an Ambler molecular class A enzyme that hydro-
lyses a broad variety of b-lactams [17]. In addition, KPC-
producing isolates demonstrate resistance to many agents
commonly used to treat Gram-negative infections,
including quinolones and aminoglycosides. The globally
distributed ST of K. pneumoniae associated with KPC
enzyme production is ST258 [17]. However, despite the
internationally prominent role of ST258, other K. pneu-
moniae STs reported as carrying KPC include STs 14, 21,
37, 45, 101, 228, 234, 257 and 259 in the United States,
and STs 277, 327, 340 and 376 in Israel [18]. The poten-
tial for the spread of plasmid encoded KPC carbapene-
mases to different strains, including those locally more
prevalent, is a serious cause of concern [17,18].
In this report, we describe the management of two
epidemiologically related cases of intra-abdominal
abscess caused by multidrug resistant K. pneumoniae
carbapenemase (KPC) 3 - producing K. pneumoniae
(Kp) Sequence Type (ST) 258 in two hospitalized surgi-
cal HIV- negative patients.
Case Presentation
Case 1
A 50 year-old woman of Italian origin and nationality was
admitted to the general surgery and emergency unit of
the “P. Giaccone” Teaching Hospital in Palermo, Italy, in
April 2010, with severe abdominal pain and chills. She
reported a three week history of abdominal discomfort
and distension, anorexia and weight loss. Her medical
history included chronic pancreatitis (CP) associated
with alcohol abuse and heavy cigarette smoking.
Upper gastro-intestinal (GI) endoscopy and colono-
scopy yielded normal findings. Relevant laboratory
values were as follows: AST 86 U/L (normal range: 0-41
U/L), ALT 87 U/L (normal range: 0-37 U/L), serum
amylase 134 U/L (normal range 53-123 U/L), lipase 356
U/L (normal range 10-150 U/L) and Bilirubin 1.8 mg/dl
(normal range 0.2-1.3 mg/dl). Oral glucose tolerance
test was normal and the patient tested negative for
HBV, HCV and HIV.
On admission, a computed tomography (CT) scan
showed a heterogeneous mass in the pancreatic head,
while the rest of the organ appeared normal. The adja-
cent intra-pancreatic common bile duct and the pan-
creatic duct were normal. There was no evidence of
vessel or lymph node involvement. The clinical suspi-
cion was CP in the exacerbation phase. After conserva-
tive treatment, the patient’ss y m p t o m sr e s o l v e da n d
laboratory data returned to within the normal range.
Four months later, the patient was re-admitted to the
same hospital unit after developing fever with a WBC
c o u n to f1 6×1 0
9/L (89% neutrophils, 7% lymphocytes,
and 4% monocytes) and serum C-reactive protein levels
(CRP) of 15 mg/dl (normal range 0.08-1.5 mg/dl). A CT
scan of the abdomen and pelvis showed a relatively
small (< 5 cm) pseudocystic lesion located in the head
of the pancreas (Figure 1). Using a 21 gauge spinal nee-
dle, a CT scan-guided percutaneous aspiration biopsy
was performed. A purulent fluid was aspirated and sub-
mitted for cytology and culture.
Cytology showed inflammatory cells without evidence
of malignancy. Culture grew a multidrug-resistant iso-
late of KPC3-Kp ST258 isolate [19]. blaKPC3 gene was
identified by polymerase chain reaction (PCR) and
sequencing, as previously reported [19].
The carbapenem non-susceptible isolate was initially
characterized by the Phoenix system (Becton Dickinson,
Sparks, MD, USA) as resistant to amikacin and
Figure 1 Computed Tomography scan after four months in
case 1. Lesion found in the head of the pancreas (arrowhead).
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microbial-drug susceptibility testing using agar dilution
and Etest (AB-Biodisk, Solna, Sweden) showed MICs in
the susceptible range for tigecycline and colistin. The
resistance pattern of the KPC-Kp isolate is shown in
Table 1.
Combined intravenous colistin (colistimethate
sodium,1 mg of colistin equals 12,500 IU) at a dosage of
5 mg/kg/day divided in 3 equal doses and tigecycline
(recommended dosage regimen 100 mg initially, fol-
lowed by 50 mg every 12 hours) was started. After six
weeks of combined antibiotic treatment, the symptoms
resolved and leukocyte count, serum amylase and lipase
returned within normal ranges. Instrumental assessment
did not show any change in the size of the lesion
throughout the observation period.
Case 2
A 64-year-old HIV-negative woman of Italian origin and
nationality was admitted in June 2010 to the surgical
oncology unit of the same hospital with a three-month
history of nausea, occasional vomiting and epigastric
and right-side abdominal pain. On admission, a rectal
swab was performed because she was enrolled in an
ongoing one-year active surveillance program of multi-
drug resistant Gram negative colonization. Culture
tested positive for a KPC3-Kp strain. Cohorting and
contact isolation procedures were implemented. An
aesophago-gastro-duodenoscopy (EGDS) tested negative
for neoplastic infiltration and duodenal stenosis. A CT
of the abdomen revealed a hypodense and inhomoge-
neous swelling of the pancreas head, compatible with a
neoplasm, and a secondary lesion at the fifth liver seg-
ment. Therefore, a pancreatic-duodenectomy with resec-
tion of the fifth and the sixth liver segment was
performed. A jejunostomy feeding tube and six abdom-
inal drainages were also placed. Histology confirmed the
diagnosis of intraductal papillary mucinous neoplasm of
the pancreas with liver metastases.
On the first post-operative day, the patient started
enteral and parenteral nutrition. Her blood tests looked
normal and she did well. On the seventh post-operative
day, she developed fever, with laboratory tests revealing
a WBC count of 19 × 10
9/L and CRP of 13.6 mg/dl. An
abdominal CT scan detected a liver lesion with air bub-
bles, consistent with an abscess in the right lobe seg-
ment (Figure 2a). Percutaneous trans-hepatic abscess
drainage was performed (Figure 2b). Culture of the drai-
nage fluid grew a multidrug-resistant ST258 KPC-Kp
Table 1 Antimicrobial susceptibility patterns of Klebsiella
pneumoniae isolates
Antimicrobial Patient 1 Patient 2
MIC(μg/ml)
Amikacin ≥ 64 ≥ 64
Ampicillin ≥32 ≥32
Aztreonam ≥ 64 ≥ 64
Cefazolin ≥64 ≥64
Cefepime 32 32
Ceftriaxone ≥ 64 ≥ 64
Ciprofloxacin ≥ 4 ≥ 4
Gentamicin 8 8
Piperacillin-tazobactam ≥ 128 ≥ 128
Tobramycin ≥ 6 ≥ 6
Trimethoprim-sulfamethoxazole ≥ 320 ≥ 320
Nitrofurantoin 256 256
Ertapenem ≥ 8 ≥ 8
Meropemen 32 32
Imipenem > 8 > 8
Moxifloxacin > 8 > 8
Tigecycline* 0,5 0,5
Polymyxin B* 0.75 0.75
MIC, minimum inhibitory concentration. * Tested by Etest
Figure 2 Post-operative Computed Tomography scan in case 2.
a. Contrast-enhanced CT scan showed metal clips due to resection
of liver segment V and VI (arrowhead) and infected lesion in VII and
VIII liver segment (day 8). b. Percutaneous trans-hepatic drainage
(day 10).
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molecular typing were carried out. The phenotypic and
genetic make-up of this isolate was indistinguishable
from that of the colonizing isolate.
Intravenous therapy with colistin and tigecycline using
the dosage and administration procedure previously
described for case 1 was started. During the first two
weeks of antibiotic therapy combined with continuous
percutaneous trans-hepatic drainage of the liver abscess,
no clinical or instrumental improvement was observed.
Repeated cultures of the drainage fluid consistently
yielded Kpc-Kp. Only after five weeks of combined
colistin and tigecycline treatment did the drainage cul-
ture test negative for KPC-Kp. The patient was even-
tually discharged after 45 days in hospital. She fully
recovered, and on follow-up she proved to have
returned to her usual state of health.
The clonal relationship between the isolates from the
two patients was investigated by pulsed-field gel electro-
phoresis (PFGE). After digestion of total genomic DNA
with restriction endonuclease Xbal, electrophoretic pat-
terns were indistinguishable.
Conclusions
The management of liver and pancreatic pyogenic
abscesses is extremely complex. A treatment of choice
that could be consistently adopted as a first line of inter-
vention has still to be defined. The literature describes a
wide range of approaches, ranging from simple conser-
vative treatments associated with specific antibiotic ther-
apy to surgical interventionist approaches using
endoscopic or percutaneous drainage or the traditional
open method [20-22]. However, while interventional
endoscopy is a common strategy across recent reports,
there is still a lot of debate over what is the best drai-
nage technique to adopt [22,23].
Both patients described in this report underwent percu-
t a n e o u sd r a i n a g ea st h e r ew a sn oe v i d e n c eo fc o m p l i c a -
tions (e.g. intra-abdominal rupture, shock, peritonitis).
This approach allowed us to diagnose the monomicrobial
nature of the abscess. Although K. pneumoniae has pre-
viously been identified in western Europe as a causative
agent of liver abscesses, monomicrobial infections, as
appeared in both of our cases, have been rarely described
[1,2].
When compared with other bacterial etiology, mono-
microbial Kp n e u m o n i a eliver abscesses are associated
with a higher incidence of thrombophlebitis and septic
hematogenous complications [6,7]. Therefore timely
diagnosis, surgery and appropriate antimicrobial treat-
ment are the mainstays to reduce mortality. Different
surgical approaches have recently been suggested in
patients with monomicrobial K. pneumoniae liver
abscess (e.g. ultrasonography-guided percutaneous liver
aspiration with retained catheter), whereas antimicrobial
therapy strictly depends upon monitoring in vitro anti-
microbial susceptibility using the clinical breakpoints
defined by the European Committee on Antimicrobial
Susceptibility Testing (EUCAST) [23,24].
The polymyxin class, known since 1947 and mostly
represented by polymyxin B and polymyxin E (colistin),
and tigecycline (the first representative of the new class
of glycylcyclines) have recently been granted a major
role in the treatment of the most problematic MDR
Gram-negative pathogens (ESBL- and carbapenemase-
producing strains) and enterobacteria. Previous studies
have reported them being used as a monotherapy for
patients with serious polymicrobial infections, including
MDR microorganisms [25,26]. Both antibiotics show
favorable penetration into various tissues, such as the
sites of infection of the skin and soft tissues of the skin,
as well as intra-abdominal infections (official indica-
tions). Apart from the ongoing effectiveness of new and
old antibiotics, another crucial concern is whether a suf-
f i c i e n tc o n c e n t r a t i o no ft h ea n t i b i o t i ci sa b l et or e a c h
the target site. It is known that penetration of an anti-
biotic into an encapsulated purulent lesion is likely to
be limited and highly dependent on the degree of
abscess maturation [27]. Tigecycline concentrations in
peritoneal fluid have also been determined, but pharma-
cokinetic and pharmacokinetics and/or tissue penetra-
tion in intra-pancreatic abscesses is unknown [2,22].
In our experience, combination therapy appeared to
be able to eradicate KPC-Kp. Though several reports
have been published about infections caused by carbape-
nem resistant Gram negative pathogen in different clini-
cal settings, no univocal data on the clinical efficacy of
mono- or combined antimicrobial therapy in patients
with liver or pancreatic abscesses are available, because
their results are often included within those of patients
with abdominal infection. In a review of current litera-
ture, Hirsch and Tam (2010), conclude that clinical suc-
cess rates are low when polymyxins are used as
monotherapy, but higher when they are used in combi-
nation with tigecycline or gentamicin [28]. Accordingly,
combined tigecycline and colistin has shown good in
vitro synergy against carbapenem resistant Acinetobacter
baumannii with high level imipenem resistance [29].
Furthermore, it is a cause for great concern that colistin
resistant ST258 KPC-Kp isolates have recently been
detected in Europe, with an outbreak occurring in our
geographical area also, while tigecycline resistance dur-
ing therapy has already been observed in ICUs and
other surgical critical care settings [19,25,30].
Future prospective studies are needed to answer
important clinical questions, such as appropriate dosage
and the most favorable pharmacokinetic/
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resistance development must be carefully monitored.
The KPC3-Kp isolates from the two patients were
found to be indistinguishable by PFGE. An epidemiolo-
gical relation between the two cases could not be
excluded. However, clonal dissemination within health-
care structures of KPC-Kp ST258 has been described in
many countries [17,18]. Moreover, an outbreak caused
by a virtually indistinguishable strain was recently
reported in another hospital in Palermo [19]. Hence,
this does not allow us to draw reliable conclusions
about the relationship between strains on the basis of
their macrorestriction profiles.
A few studies have tried to explain the occurrence or
portal of entry of MDR pathogens in surgical popula-
tions by involving the portal venous system or mesen-
teric lymph nodes [14,31]. In case 2, the patient was
already colonized at admission and her clinical history
was positive for previous hospitalization. In this case,
intra-operative spread of colonizing KPC-Kp through
the mentioned mechanisms can be hypothesized.
As a new diagnostic perspective, intra-operative bac-
terial translocation detection by bacterium-specific ribo-
somal RNA-targeted reverse-transcriptase PCR from
lymph nodes has been described as able to predict post-
operative infectious complications after major hepatic
surgery whereas as new therapeutic perspective time-kill
methodology has been described as able to investigate
the in vitro interaction of antimicrobial combination
[32].
Finally, strict infection control procedures according
to the guidelines of the Centers for Disease Control and
Prevention (CDC) for infection with carbapenem-resis-
tant or carbapenemase-producing Enterobacteriaceae in
acute care facilities are crucial in an era of crisis regard-
ing the availability and effectiveness of antimicrobials
[33].
In conclusion, two interesting findings emerge from
these case reports. Firstly, adequate drainage along with
an appropriate long term antibiotic therapy may lead to
a favorable outcome in serious infectious events, such as
liver and pancreatic abscesses. Secondly, the emergence
and dissemination of MDR organisms is posing an
increasing challenge for physicians to develop new ther-
apeutic strategies and control and prevention
frameworks.
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